Illinois 2023-2024 Regular Session

Illinois House Bill HB5517

Introduced
2/9/24  
Introduced
2/9/24  
Refer
3/5/24  
Refer
2/9/24  
Refer
4/5/24  
Refer
3/5/24  
Refer
4/5/24  
Refer
4/5/24  

Caption

HEALTH CARE COSTS ACT

Impact

Furthermore, HB5517 introduces regulations for pharmaceutical marketing firms, requiring them to register with the Department of Financial and Professional Regulation and disclose a list of their representatives. This registration aims to promote transparency within pharmaceutical marketing and ensure that healthcare providers receive accurate information regarding drug pricing and availability. Additionally, the bill places emphasis on the regulation of pharmacy benefit managers, requiring reports on their practices to inform consumers about potential cost savings and the distribution of prescription drugs.

Summary

House Bill 5517, titled the Protection Against Unnecessary Health Care Costs Act, aims to establish measures to reduce healthcare costs for residents of Illinois by creating a Drug Discount Card Program. This program requires the State Comptroller to make a discount card available to all residents, enabling them to access lower prices for prescription drugs through collective purchasing power. The bill also mandates that the Department of Insurance provide recommendations for an outreach program to inform healthcare providers about generic drugs that become available after patents expire, thereby promoting the use of more affordable alternatives.

Contention

While proponents argue that this legislation will significantly benefit consumers by lowering medication costs and enhancing transparency in healthcare pricing, critics have raised concerns about the potential regulatory burden on pharmaceutical firms and the implications for existing health service models. Specific points of contention arise around the costs associated with implementing the Drug Discount Card Program and whether it will truly translate into savings for consumers. Furthermore, the strict regulations on pharmaceutical marketing could impact how these companies engage with medical professionals, potentially limiting necessary informational exchanges.

Notable_points

Notably, the Act also amends the Illinois Health Facilities Planning Act to require healthcare facilities to notify the public of their intent to file for a certificate of need. This change aims to increase community involvement in healthcare facility developments and ensure that service expansions align with public health needs. The bill seeks to engage and inform residents about their healthcare costs while striving to maintain regulation over medical practices to foster a more transparent and affordable healthcare system.

Companion Bills

No companion bills found.

Similar Bills

CT HB06669

An Act Protecting Patients And Prohibiting Unnecessary Health Care Costs.

VA HB287

Cannabis; replaces the term "marijuana" throughout the Cannabis Control Act.

VA SB788

Medical cannabis program; transition from Board of Pharmacy to Virginia Cannabis Control Authority.

VA HB1597

Medical cannabis program; transition from Board of Pharmacy to Virginia Cannabis Control Authority.

VA HB1598

Medical cannabis program; transition from Bd. of Pharmacy to Va. Cannabis Control Authority, report.